J&J issues warning after teen dies from Benadryl TikTok challenge
September 3, 2020Medical Communications
One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …
Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+
September 2, 2020Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma
Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …
US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO
September 2, 2020Research and Development Trump, Trump Administration, US, USA
The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …
Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK
September 2, 2020Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes
Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
Nestlé to acquire remaining shares in Aimmune for $2.6 billion
September 2, 2020Research and Development, Sales and Marketing Aimmune, acquisition, nestle, pharma
Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …
Pharmafile.com’s weekly COVID-19 news round-up
September 2, 2020Research and Development
The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food …
Daiichi Sankyo’s Nilemdo “significantly” reduces cholesterol levels at ESC 2020
September 1, 2020Manufacturing and Production, Research and Development Daiichi Sankyo, Nilemdo, pharma
Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …
Oxford University’s COVID-19 vaccine begins Phase 3 trial in the US
September 1, 2020Manufacturing and Production
AstraZeneca has started a Phase 3 trial of its experimental coronavirus vaccines in the US, making it the third company …
Hong Kong rolls out free universal coronavirus testing programme
September 1, 2020Manufacturing and Production
Hong Kong has begun a free universal COVID-19 testing programme to help combat the coronavirus. This mass testing system will …
Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment
September 1, 2020Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma
Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …
AstraZeneca’s Farxiga combo shows promise at Phase 3 in late-stage chronic kidney disease
September 1, 2020Manufacturing and Production AstraZeneca, ESC Congress 2020, pharma
AstraZeneca took the opportunity at the digital ESC Congress 2020 over the weekend to reveal promising new Phase 3 data …
University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial
August 28, 2020Medical Communications Cancer, Cancers, breast cancer
A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …
US signs deal to buy 150 million rapid COVID-19 tests from Abbott
August 28, 2020Medical Communications
The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use …
First clinical trial for MDMA and LSD combination set to go ahead
August 28, 2020Medical Communications LSD, MDMA, PTSD
Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …
Korea approves Celltrion’s Phase 1 trial of COVID-19 antiviral antibody treatment
August 28, 2020Medical Communications COVID-19, antibodies, coronavirus vaccine
Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug …
Top Ten most popular articles on Pharmafile.com this week
August 28, 2020Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10
The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …
Obesity increases risk of death from coronavirus and could make vaccines less effective
August 27, 2020Medical Communications obesity
Obesity can increase the risk of death from coronavirus by nearly 50% and could make a vaccine less effective, according …
Genexine’s cytokine drug effective in treating coronavirus patients, new study suggests
August 27, 2020Research and Development COVID-19
Genexine’s recent clinical trial investigating how its cytokine therapy treats coronavirus has proven effective, according to the company.
Moderna says its COVID-19 vaccine shows promise in elderly patients
August 27, 2020Research and Development Moderna vaccine, Operation Warp Speed
Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in …
FDA approves Abbott’s rapid portable COVID-19 test
August 27, 2020Research and Development Abbott, COVID-19, FDA, test
The FDA has given emergency clearance for Abbott’s portable COVID-19 test that it will sell for just $5. The company’s …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
